share_log

金石亚药:拟对合并海南亚洲制药股份有限公司形成的商誉进行减值测试所涉及的资产组组合可回收价值资产评估报告

Sichuan Goldstone: Assessment report on the recoverable value assets of the asset group portfolio involved in the proposed impairment test of goodwill formed by merging Hainan Asia Pharmaceutical Co., Ltd.

SZSI ·  Apr 26, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more